BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

616 related articles for article (PubMed ID: 20031164)

  • 1. Clinical significance of immunohistochemically-identified lymphatic and/or blood vessel tumor invasion in gastric cancer.
    Kim JH; Park SS; Park SH; Kim SJ; Mok YJ; Kim CS; Lee JH; Kim YS
    J Surg Res; 2010 Aug; 162(2):177-83. PubMed ID: 20031164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic role of lymphatic vessel invasion in early gastric cancer: a retrospective study of 188 cases.
    Liu C; Zhang R; Lu Y; Li H; Lu P; Yao F; Jin F; Xu H; Wang S; Chen J
    Surg Oncol; 2010 Mar; 19(1):4-10. PubMed ID: 19042124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of minimally invasive treatment for early gastric cancer.
    Hyung WJ; Cheong JH; Kim J; Chen J; Choi SH; Noh SH
    J Surg Oncol; 2004 Mar; 85(4):181-5; discussion 186. PubMed ID: 14991872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphatic, blood vessel and perineural invasion identifies early-stage high-risk radically resected gastric cancer patients.
    Scartozzi M; Galizia E; Verdecchia L; Berardi R; Graziano F; Catalano V; Giordani P; Mari D; Silva RR; Marmorale C; Zingaretti C; Cascinu S
    Br J Cancer; 2006 Aug; 95(4):445-9. PubMed ID: 16880789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of perineural invasion in patients with gastric cancer who underwent curative resection.
    Bilici A; Seker M; Ustaalioglu BB; Kefeli U; Yildirim E; Yavuzer D; Aydin FM; Salepci T; Oncel M; Gumus M
    Ann Surg Oncol; 2010 Aug; 17(8):2037-44. PubMed ID: 20333555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic impact of lymphatic invasion in patients with node-negative gastric cancer.
    Ichikawa D; Kubota T; Kikuchi S; Fujiwara H; Konishi H; Tsujiura M; Ikoma H; Nakanishi M; Okamoto K; Sakakura C; Ochiai T; Kokuba Y; Otsuji E
    J Surg Oncol; 2009 Aug; 100(2):111-4. PubMed ID: 19475584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors related to lymph node metastasis and the feasibility of endoscopic mucosal resection for treating poorly differentiated adenocarcinoma of the stomach.
    Park YD; Chung YJ; Chung HY; Yu W; Bae HI; Jeon SW; Cho CM; Tak WY; Kweon YO
    Endoscopy; 2008 Jan; 40(1):7-10. PubMed ID: 18210339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of lymphatic and/or blood vessel invasion in stage II gastric cancer.
    Du CY; Chen JG; Zhou Y; Zhao GF; Fu H; Zhou XK; Shi YQ
    World J Gastroenterol; 2012 Jul; 18(27):3610-6. PubMed ID: 22826628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced gastric cancer with early cancer macroscopic appearance: is it worthy of D2 lymphadenectomy?
    Sun Z; Wang ZN; Zhu GL; Huang BJ; Li K; Xu Y; Li DM; Xu HM
    Ann Surg Oncol; 2010 May; 17(5):1278-90. PubMed ID: 20058192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrence in early gastric cancer--presence of micrometastasis in lymph node of node negative early gastric cancer patient with recurrence.
    Saito H; Osaki T; Murakami D; Sakamoto T; Kanaji S; Ohro S; Tatebe S; Tsujitani S; Ikeguchi M
    Hepatogastroenterology; 2007 Mar; 54(74):620-4. PubMed ID: 17523336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significant prognostic factors in patients with early gastric cancer.
    Yokota T; Kunii Y; Teshima S; Yamada Y; Saito T; Takahashi M; Kikuchi S; Yamauchi H
    Int Surg; 2000; 85(4):286-90. PubMed ID: 11589593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic impact of isolated tumor cells in lymph nodes of T2N0 gastric cancer: comparison of American and Japanese gastric cancer patients.
    Fukagawa T; Sasako M; Shimoda T; Sano T; Katai H; Saka M; Mann GB; Karpeh M; Coit DG; Brennan MF
    Ann Surg Oncol; 2009 Mar; 16(3):609-13. PubMed ID: 19137375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The significances of lymph node micrometastasis and its correlation with E-cadherin expression in pT1-T3N0 gastric adenocarcinoma.
    Kim JH; Park JM; Jung CW; Park SS; Kim SJ; Mok YJ; Kim CS; Chae YS; Bae JW
    J Surg Oncol; 2008 Feb; 97(2):125-30. PubMed ID: 18095267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is tumor size a prognostic indicator for gastric carcinoma?
    Yokota T; Ishiyama S; Saito T; Teshima S; Yamada Y; Iwamoto K; Takahashi M; Murata K; Yamauchi H
    Anticancer Res; 2002; 22(6B):3673-7. PubMed ID: 12552975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathologic characteristics and surgical outcomes of mucinous gastric carcinoma.
    Kunisaki C; Akiyama H; Nomura M; Matsuda G; Otsuka Y; Ono HA; Shimada H
    Ann Surg Oncol; 2006 Jun; 13(6):836-42. PubMed ID: 16604474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of long-term results of radical gastrectomy combining splenectomy for gastric cancer].
    Han FH; Zhan WH; Li YM; He YL; Peng JS; Ma JP; Wang Z; Chen ZX; Zheng ZQ; Wang JP; Huang YH; Dong WG
    Zhonghua Wai Ke Za Zhi; 2005 Sep; 43(17):1114-7. PubMed ID: 16194307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of lymphovascular invasion in patients with stage I gastric cancer.
    Kunisaki C; Makino H; Kimura J; Takagawa R; Kosaka T; Ono HA; Akiyama H; Fukushima T; Nagahori Y; Takahashi M
    Surgery; 2010 Feb; 147(2):204-11. PubMed ID: 19878963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of the ratio between metastatic and dissected lymph nodes (n ratio) in patients with advanced gastric cancer.
    Saito H; Fukumoto Y; Osaki T; Yamada Y; Fukuda K; Tatebe S; Tsujitani S; Ikeguchi M
    J Surg Oncol; 2008 Feb; 97(2):132-5. PubMed ID: 17979134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive factors for lymph node metastasis in early gastric cancer with submucosal invasion: analysis of a single institutional experience.
    An JY; Baik YH; Choi MG; Noh JH; Sohn TS; Kim S
    Ann Surg; 2007 Nov; 246(5):749-53. PubMed ID: 17968165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is bursectomy necessary for patients with gastric cancer invading the serosa?
    Yoshikawa T; Tsuburaya A; Kobayashi O; Sairenji M; Motohashi H; Hasegawa S; Ishiwa N; Morinaga S; Noguchi Y; Yamamoto Y; Matsumoto A
    Hepatogastroenterology; 2004; 51(59):1524-6. PubMed ID: 15362792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.